Facial Fat Loss

Medications for Facial Lipoatrophy

Other names: Facial Weight Loss; Facial Wasting; Lipoatrophy, Facial

Concerning Facial Lipoatrophy: Facial Lipoatrophy is the loss of subcutaneous fat onto the facial skin area.

The following list of medications have been somehow related to, or found in the treating this condition.

Medication name	Rx / OTC	Pregnancy	CSA	Reviews	Rating
Sculptra	Rx	N	N	Insert review	0.0
Generic name: poly-l-lactic acid systemic Medication course: amalgamated uncategorized brokers For users:

poly-l-lactic acid	Rx	N	N	Insert review	0.0
Generic name: poly-l-lactic acid systemic Brand name: Sculptra Medication course: amalgamated uncategorized brokers For users: For professionals: az Drug Facts

Rx	Prescription Only
OTC	On The Counter
Rx/OTC	Prescription or Over the Counter
Away Prizes	This drug may not be accepted by the FDA for the treatment of this condition.

Pregnancy Category
A	Adequate and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (also there is no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women.
C	Animal research studies have shown a negative effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks.
D	There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in pregnant women clearly outweigh potential rewards.
N	FDA have not classified the medication.

Controlled Substances Act (CSA) Schedule
N	isn`t subject to the Controlled Substances Act.
1	features a higher potential for abuse. Has no accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
Two	features a higher potential for abuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may lead to acute emotional or physical dependence.
3	includes a potential for abuse less than those in programs 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4	features a minimal potential for abuse in accordance with those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5	features a minimal potential for abuse in accordance with those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence.

Infection
X	Interacts with Alcohol.

Always seek advice from your physician to be sure the information displayed on these pages relates to your circumstances.